| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Thierry Poynard | Q43252014 |
| Nezam Afdhal | Q60650815 | ||
| P2093 | author name string | John McHutchison | |
| International Fibrosis Group Meeting Participants | |||
| P2860 | cites work | Diagnosis of chronic liver disease: reproducibility and validation of liver biopsy | Q43897261 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver disease | Q929737 |
| P304 | page(s) | 1214-1220 | |
| P577 | publication date | 2006-09-18 | |
| P1433 | published in | Clinical Gastroenterology and Hepatology | Q5133759 |
| P1476 | title | Fibrosis as an end point for clinical trials in liver disease: a report of the international fibrosis group | |
| P478 | volume | 4 |
| Q37536973 | Assessment of liver fibrosis: noninvasive means |
| Q51018265 | Beyond scoring: a modern interpretation of disease progression in chronic liver disease. |
| Q37323789 | Biomarkers of liver fibrosis |
| Q58622691 | Chapter 4 Biomarkers Of Liver Fibrosis |
| Q37411941 | Comparison of the liver stiffness measurement by transient elastography with the liver biopsy. |
| Q84250608 | Detection of non-alcoholic steatohepatitis in patients with morbid obesity before bariatric surgery: preliminary evaluation with acoustic radiation force impulse imaging |
| Q36912964 | Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review |
| Q40126822 | Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment |
| Q42239858 | Does low-dose prolonged steroid therapy affect the natural history of chronic hepatitis C? |
| Q38303313 | Early to Phase II drugs currently under investigation for the treatment of liver fibrosis |
| Q84809394 | Feasibility study and control values of transient elastography in healthy children |
| Q51645420 | Fibroscan: a new noninvasive method for evaluation of liver dysfunction in Turner syndrome. |
| Q34469006 | Liver biopsy for histological assessment: The case against |
| Q30448132 | Liver elastography, comments on EFSUMB elastography guidelines 2013. |
| Q40913201 | Longitudinal assessment of hepatitis C fibrosis progression by collagen and smooth muscle actin morphometry in comparison to serum markers |
| Q35810531 | Markers of inflammation and fibrosis in alcoholic hepatitis and viral hepatitis C |
| Q37313574 | Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update |
| Q33904205 | Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection |
| Q34476310 | Multiplex protein analysis to determine fibrosis stage and progression in patients with chronic hepatitis C. |
| Q37002423 | Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay |
| Q50221691 | Real-time tissue elastography (RTE) for noninvasive evaluation of fibrosis in liver diseases in children in comparison to liver biopsy |
| Q30479169 | Ultrasonic elastography in clinical quantitative assessment of fatty liver |
| Q30432218 | Ultrasound in chronic liver disease |
| Q26778038 | Ultrasound-based elastography for the diagnosis of portal hypertension in cirrhotics |
| Q46636339 | Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease |
Search more.